Previous studies have shown that PXN-AS1 is involved in the regulation of the occurrence, metastasis and drug resistance of malignant tumors such as liver cancer, nasopharyngeal carcinoma, non-small cell lung cancer and malignant glioma [24–29]. This evidence concerns the gene PXN and nasopharyngeal carcinoma.